22.35
-0.87(-3.75%)
Currency In USD
| Previous Close | 23.22 |
| Open | 23.17 |
| Day High | 23.22 |
| Day Low | 22.13 |
| 52-Week High | 26.58 |
| 52-Week Low | 19.05 |
| Volume | 1.86M |
| Average Volume | 1.28M |
| Market Cap | 2.75B |
| PE | 13.07 |
| EPS | 1.71 |
| Moving Average 50 Days | 22.96 |
| Moving Average 200 Days | 22.19 |
| Change | -0.87 |
If you invested $1000 in Catalyst Pharmaceuticals, Inc. (CPRX) 10 years ago, it would be worth $10,252.29 as of January 14, 2026 at a share price of $22.35. Whereas If you bought $1000 worth of Catalyst Pharmaceuticals, Inc. (CPRX) shares 5 years ago, it would be worth $6,331.44 as of January 14, 2026 at a share price of $22.35.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
GlobeNewswire Inc.
Jan 08, 2026 1:03 PM GMT
CORAL GABLES, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
GlobeNewswire Inc.
Jan 05, 2026 1:03 PM GMT
Students from The University of Notre Dame Selected to Participate in a Week-long Biopharmaceutical Learning IntensiveCORAL GABLES, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The University of Notre Dame and Catalyst Pharmaceuticals, Inc. (“Catalyst”
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 15, 2025 1:03 PM GMT
CORAL GABLES, Fla., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for